Sangeeta N. Bhatia

Director, Marble Center for Cancer Nanomedicine
John J. and Dorothy Wilson Professor of Health Sciences and Technology & Electrical Engineering and Computer Science
Investigator, Howard Hughes Medical Institute

Trained as both a physician and engineer, Dr. Sangeeta Bhatia has pioneered technologies for interfacing living cells with synthetic systems, enabling new applications in tissue regeneration, stem cell differentiation, medical diagnostics and drug delivery. Her multidisciplinary team has developed a broad and impactful range of inventions, including human micro livers which model human drug metabolism, liver disease, and interaction with pathogens, and a suite of communicating nanomaterials that can be used to interrogate, monitor and treat cancer and other diseases. Her work has been profiled broadly such as in Scientific American, the Boston Globe, Popular Science, Forbes, PBS’s NOVA scienceNOW, The Economist, and MSNBC. Dr. Bhatia trained at Brown, MIT, Harvard, and MGH. She is an elected member of the National Academy of Engineering and the American Academy of Arts and Sciences, and she is a fellow of the Massachusetts Academy of Sciences, the Biomedical Engineering Society, the American Institute for Medical and Biological Engineering, and the American Society for Clinical Investigation. She has been awarded the 2015 Heinz Award for Technology, the Economy and Employment; the 2014 Lemelson-MIT Prize; the David and Lucile Packard Fellowship given to “the nation’s most promising young professors in science and engineering;” the NSF CAREER Award; the Y.C. Fung Young Investigator Award of the American Society of Mechanical Engineers; the Young Investigator Award of the American College of Clinical Pharmacology; and the Brown Engineering Alumni Medal. She also was named a Merkin Fellow of the Broad Institute.

For more information on the Bhatia Lab, click here.


Daniel G. Anderson

Samuel A. Goldblith Professor of Applied Biology
Associate Professor, Chemical Engineering and Institute for Medical Engineering and Science

Dr. Daniel Anderson is the Samuel A. Goldblith Professor of Applied Biology, Associate Professor, Chemical Engineering and Institute for Medical Engineering and Science, and member of the Koch Institute for Integrative Cancer Research at MIT. He received his PhD in molecular genetics from the University of California at Davis. At MIT, he pioneered the use of robotic methods for the development of smart biomaterials for drug delivery and medical devices. His work has led to the first methods rapid synthesis, formulation, analysis, and biological evaluation of large libraries of biomaterials for use in medical devices, cell therapy and drug delivery. In particular, the advanced drug delivery systems he has developed provide new methods for nanoparticulate drug delivery, non-viral gene therapy, siRNA delivery, and vaccines. His work has resulted in the publication of over 230 papers, patents and patent applications. These patents have led to a number of licenses to pharmaceutical, chemical and biotechnology companies, and a number of products that have been commercialized or are in clinical development.

For more information on the Anderson Lab, click here.


Angela M. Belcher

James Mason Crafts Professor
Professor of Biological Engineering and Materials Science

Dr. Angela Belcher is a material scientist, biological engineer, and professor at MIT. She attended the University of California, Santa Barbara, where she received her Bachelor's degree from the College of Creative Studies in 1991 and her Ph.D. in chemistry in 1997. Dr. Belcher was awarded the 24th annual MacArthur Foundation Fellowship, and the 2004 Four Star General Recognition Award. In 2006 she was named Scientific American’s Research Leader of the Year. Her work has been published in many prestigious scientific journals including Science and Nature, and has been reported in the popular press including Fortune, Forbes, Discover, The New York Times, and The Wall Street Journal.

For more information on the Belcher Lab, click here.


Paula T. Hammond

David H. Koch Professor in Engineering

Dr. Paula Hammond is the David H. Koch Professor in Engineering and head of the Department of Chemical Engineering at MIT. She received her S.B. in Chemical Engineering from MIT in 1984, her M.S. from Georgia Tech in 1988, and earned her Ph.D. from MIT in 1993. In 1994, she was awarded the NSF Postdoctoral Fellowship in Chemistry while performing postdoctoral research in the Harvard University Chemistry Dept as a member of the Whitesides research group. In 2000, she was awarded the Junior Bose Faculty Award, and the GenCorp Signature University Award. She has also received the NSF Career Award, the EPA Early Career Award, the DuPont Young Faculty Award, and the 3M Innovation Fund Award. Recently, The Harvard Foundation presented Dr. Hammond the 2010 Scientist of the Year Award as part of its annual Albert Einstein Science Conference: Advancing Minorities and Women in Science, Engineering, and Mathematics. Dr. Hammond was also one of a group of key faculty members involved in starting the Institute for Soldier Nanotechnologies, and in 2015, she was named head of MIT's Department of Chemical Engineering.

For more information on the Hammond Lab, click here.


Darrell J. Irvine

Professor of Biological Engineering and Materials Sciences & Engineering
Investigator, Howard Hughes Medical Institute

Darrell Irvine, Ph.D., is a Professor at the Massachusetts Institute of Technology and an Investigator of the Howard Hughes Medical Institute. He also serves on the steering committee of the Ragon Institute of MGH, MIT, and Harvard. His research is focused on the application of engineering tools to problems in cellular immunology and the development of new materials for vaccine and drug delivery.  Current efforts are focused on problems related to vaccine development for HIV and and immunotherapy of cancer. This interdisciplinary work has been recognized in numerous awards, including a Beckman Young Investigator award, an NSF CAREER award, selection for Technology Review’s ‘TR35’, election as a Fellow of the Biomedical Engineering Society, and appointment as an investigator of the Howard Hughes Medical Institute.  He is the author of over 70 publications, reviews, and book chapters and an inventor on numerous patents.

For more information on the Irvine Lab, click here.


Robert S. Langer

David H. Koch Institute Professor

Robert S. Langer is the David H. Koch Institute Professor (there are 11 Institute Professors at MIT; being an Institute Professor is the highest honor that can be awarded to a faculty member). Dr. Langer has written over 1,250 articles. He also has nearly 1,050 patents worldwide. Dr. Langer’s patents have been licensed or sublicensed to over 250 pharmaceutical, chemical, biotechnology and medical device companies. He is the most cited engineer in history. He served as a member of the United States Food and Drug Administration’s SCIENCE Board, the FDA’s highest advisory board, from 1995 – 2002 and as its Chairman from 1999-2002. Research at the Langer Lab is at the interface of biotechnology and materials science. The major focus is the study and development of polymers to serve as scaffolds for tissue engineering and as vehicles for controlled delivery of drugs including small molecules, proteins, DNA and RNAi. The Langer group is also devoted to inventing novel medical devices for diagnosis and therapeutics. The lab has also established several high-throughput screening platforms for new drug development and vaccine design to treat cancers and other diseases. Last but not least, the Langer group is interested in cell engineering via chemical and genetic tools for cancer immunotherapy and stem cell therapy.

For more information on the Langer Lab, click here.


Tarek R. Fadel

Assistant Director, Marble Center for Cancer Nanomedicine

Tarek R. Fadel is the Assistant Director of the Marble Center for Cancer Nanomedicine at the MIT Koch Institute for Integrative Cancer Research. Before joining MIT, Dr. Fadel was a Staff Scientist at the National Nanotechnology Coordination Office (NNCO), the coordinating body for the U.S. National Nanotechnology Initiative (NNI). During his time at NNCO, he served as the Executive Secretary for the Nanoscale Science, Engineering, and Technology (NSET) Subcommittee of the White House’s National Science and Technology Council's Committee on Technology. Dr. Fadel received his PhD from Yale University in 2011—where he currently serves as a board member of the Graduate School Alumni Association—and previously held positions as Vice President for Research at the International Technology Research Institute, and Product and Systems Interaction Engineer at Hewlett Packard. Dr. Fadel is lead author of several peer-reviewed publications in the fields of nanomedicine, cancer immunotherapy, and biophysics.

For more information about the Marble Center, please contact Tarek Fadel at tfadel@mit.edu